JP5611814B2 - Ｍｅｋリガンドおよびｍｅｋリガンドをコードするポリヌクレオチド - Google Patents

Ｍｅｋリガンドおよびｍｅｋリガンドをコードするポリヌクレオチド Download PDF

Info

Publication number
JP5611814B2
JP5611814B2 JP2010501233A JP2010501233A JP5611814B2 JP 5611814 B2 JP5611814 B2 JP 5611814B2 JP 2010501233 A JP2010501233 A JP 2010501233A JP 2010501233 A JP2010501233 A JP 2010501233A JP 5611814 B2 JP5611814 B2 JP 5611814B2
Authority
JP
Japan
Prior art keywords
seq
amino acid
polypeptide
ligand
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010501233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010522568A5 (enExample
JP2010522568A (ja
Inventor
バチンスキー，デイビッド
カーソン，ジョナソン
アッゼル，エイミー
リード，トマス
Original Assignee
イントレキソン コーポレーション
イントレキソン コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イントレキソン コーポレーション, イントレキソン コーポレーション filed Critical イントレキソン コーポレーション
Publication of JP2010522568A publication Critical patent/JP2010522568A/ja
Publication of JP2010522568A5 publication Critical patent/JP2010522568A5/ja
Application granted granted Critical
Publication of JP5611814B2 publication Critical patent/JP5611814B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11024—Mitogen-activated protein kinase (2.7.11.24), i.e. MAPK or MAPK2 or c-Jun N-terminal kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/12—Dual-specificity kinases (2.7.12)
    • C12Y207/12002—Mitogen-activated protein kinase kinase (2.7.12.2), i.e. MAPKK or MEK1 or MEK2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2010501233A 2007-03-27 2008-03-27 Ｍｅｋリガンドおよびｍｅｋリガンドをコードするポリヌクレオチド Expired - Fee Related JP5611814B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90823107P 2007-03-27 2007-03-27
US60/908,231 2007-03-27
PCT/US2008/058531 WO2008119058A2 (en) 2007-03-27 2008-03-27 Mek ligands and polynucleotides encoding mek ligands

Publications (3)

Publication Number Publication Date
JP2010522568A JP2010522568A (ja) 2010-07-08
JP2010522568A5 JP2010522568A5 (enExample) 2011-10-06
JP5611814B2 true JP5611814B2 (ja) 2014-10-22

Family

ID=39789285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010501233A Expired - Fee Related JP5611814B2 (ja) 2007-03-27 2008-03-27 Ｍｅｋリガンドおよびｍｅｋリガンドをコードするポリヌクレオチド

Country Status (11)

Country Link
US (2) US8575304B2 (enExample)
EP (2) EP2126064B1 (enExample)
JP (1) JP5611814B2 (enExample)
KR (1) KR101557167B1 (enExample)
CN (1) CN101679956A (enExample)
AU (1) AU2008230711B9 (enExample)
CA (1) CA2680837C (enExample)
DK (1) DK2126064T3 (enExample)
ES (1) ES2390156T3 (enExample)
IL (1) IL201192A (enExample)
WO (1) WO2008119058A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153598B2 (en) 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
US7943732B2 (en) 2006-06-05 2011-05-17 Intrexon Corporation AKT ligands and polynucleotides encoding AKT ligands
US8993263B2 (en) 2006-08-07 2015-03-31 Intrexon Corporation PKA ligands and polynucleotides encoding PKA ligands
US8999666B2 (en) 2006-08-09 2015-04-07 Intrexon Corporation PKC ligands and polynucleotides encoding PKC ligands
US8729225B2 (en) 2006-11-13 2014-05-20 Intrexon Corporation Glycogen synthase kinase heteropolyligand polypeptide
US8283445B2 (en) 2006-11-13 2012-10-09 Intrexon Corporation Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
US7705122B2 (en) 2006-12-04 2010-04-27 Intrexon Corporation mTOR ligands and polynucleotides encoding mTOR ligands
US8575304B2 (en) 2007-03-27 2013-11-05 Intrexon Corporation MEK ligands and polynucleotides encoding MEK ligands
CA2685592C (en) 2007-05-02 2018-08-07 Intrexon Corporation Pp1 ligands
US8431363B2 (en) * 2008-01-09 2013-04-30 Intrexon Corporation Polynucleotides encoding therapeutic inhibitors of PAI-1

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904395D0 (en) 1999-02-25 1999-04-21 Fluorescience Ltd Protein assay
AUPR230500A0 (en) * 2000-12-22 2001-01-25 University Of Newcastle Research Associates Limited, The A method of modulating map kinase mediated cellular activity and agents useful in same
US20050089932A1 (en) 2001-04-26 2005-04-28 Avidia Research Institute Novel proteins with targeted binding
AU2002348791A1 (en) * 2001-12-21 2003-07-09 Warner-Lambert Company Llc Modified mek1 and mek2, crystal of a peptide: ligand: cofactor complex containing such modified mek1 or mek2, and methods of use thereof
AU2003245627A1 (en) * 2002-06-21 2004-01-06 Incyte Corporation Kinases and phosphatases
US7785871B2 (en) 2002-10-09 2010-08-31 Intrexon Corporation DNA cloning vector plasmids and methods for their use
US20080050808A1 (en) 2002-10-09 2008-02-28 Reed Thomas D DNA modular cloning vector plasmids and methods for their use
US7071295B2 (en) 2002-12-02 2006-07-04 Intrexon Corporation Signal for targeting molecules to the sarco(endo)plasmic reticulum
US20080220497A1 (en) 2003-12-24 2008-09-11 Flynn Daniel L Modulation of protein functionalities
WO2005113812A2 (en) * 2004-04-23 2005-12-01 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
CN1981047B (zh) 2004-05-18 2013-08-21 英特拉克森公司 Dna克隆载体质粒的动态载体装配方法
WO2006039367A2 (en) * 2004-10-01 2006-04-13 Mount Sinai School Of Medicine Of New York University Resonance energy transfer system and method
WO2007048103A2 (en) 2006-10-18 2007-04-26 Intrexon Corporation Pkd ligands and polynucleotides encoding pkd ligands
US8153598B2 (en) 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
US7943732B2 (en) 2006-06-05 2011-05-17 Intrexon Corporation AKT ligands and polynucleotides encoding AKT ligands
US8993263B2 (en) 2006-08-07 2015-03-31 Intrexon Corporation PKA ligands and polynucleotides encoding PKA ligands
US8999666B2 (en) 2006-08-09 2015-04-07 Intrexon Corporation PKC ligands and polynucleotides encoding PKC ligands
US8283445B2 (en) 2006-11-13 2012-10-09 Intrexon Corporation Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
US8729225B2 (en) 2006-11-13 2014-05-20 Intrexon Corporation Glycogen synthase kinase heteropolyligand polypeptide
US7705122B2 (en) 2006-12-04 2010-04-27 Intrexon Corporation mTOR ligands and polynucleotides encoding mTOR ligands
US7927987B2 (en) 2007-03-27 2011-04-19 Texas Instruments Incorporated Method of reducing channeling of ion implants using a sacrificial scattering layer
US8575304B2 (en) 2007-03-27 2013-11-05 Intrexon Corporation MEK ligands and polynucleotides encoding MEK ligands

Also Published As

Publication number Publication date
DK2126064T3 (da) 2012-09-10
IL201192A (en) 2014-11-30
HK1138876A1 (en) 2010-09-03
AU2008230711B2 (en) 2014-03-27
WO2008119058A9 (en) 2008-12-24
EP2537924B1 (en) 2015-03-18
EP2537924A2 (en) 2012-12-26
US9006390B2 (en) 2015-04-14
EP2537924A3 (en) 2013-04-10
WO2008119058A2 (en) 2008-10-02
EP2126064A2 (en) 2009-12-02
AU2008230711A1 (en) 2008-10-02
US20140073028A1 (en) 2014-03-13
CA2680837C (en) 2017-06-06
IL201192A0 (en) 2011-08-01
CA2680837A1 (en) 2008-10-02
KR20100015944A (ko) 2010-02-12
KR101557167B1 (ko) 2015-10-02
CN101679956A (zh) 2010-03-24
WO2008119058A3 (en) 2009-02-12
EP2126064A4 (en) 2010-06-23
US8575304B2 (en) 2013-11-05
EP2126064B1 (en) 2012-06-06
AU2008230711B9 (en) 2014-08-21
JP2010522568A (ja) 2010-07-08
ES2390156T3 (es) 2012-11-07
US20100279378A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
JP5611814B2 (ja) Ｍｅｋリガンドおよびｍｅｋリガンドをコードするポリヌクレオチド
US8993531B2 (en) PKD ligands and polynucleotides encoding PKD ligands
US9315786B2 (en) GSK3 ligands and polynucleotides encoding GSK3 ligands
US9493525B2 (en) AKT ligands and polynucleotides encoding AKT ligands
US8283445B2 (en) Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
US9301992B2 (en) mTOR ligands and polynucleotides encoding mTOR ligands
US8999666B2 (en) PKC ligands and polynucleotides encoding PKC ligands
WO2007048103A2 (en) Pkd ligands and polynucleotides encoding pkd ligands
HK1138876B (en) Mek ligands and polynucleotides encoding mek ligands

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100407

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110324

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110810

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20111005

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20111005

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20111107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130619

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140623

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140715

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140805

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140903

R150 Certificate of patent or registration of utility model

Ref document number: 5611814

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees